(Total Views: 361)
Posted On: 03/02/2021 6:08:25 AM
Post# of 22443
Marriage made in heaven? Up we go!
PNJ1204 previously posted the case study but read it carefully!
Synergy, synergy, synergy.......... Rarely do we see two companies a Goliath and a David or little engine that could working in tandem!!!
From the Innova Medical Group Case Study on the Pasaca website...
“As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.”
So the anti-counterfeiting is ready for the Innova tests.
Read More: https://investorshangout.com/post/view?id=606...z6nx3NfyIu
Challenge
With pioneering technology and numerous potential applications, Quantum leadership made a strategic decision to list on NASDAQ , however early estimations were below value expectations. To better position itself for growth, Quantum needed capital support aligned with strategic partners for visibility and expansion into new markets, industries, and geographies.
Pasaca Impact
Pasaca Capital’s controlling investment in Quantum began with financing ongoing software/App development and sourcing leadership hires, such as the COO from their exclusive network. To secure sustainable revenue and profitability to fund growth, Pasaca facilitated a distribution agreement between Quantum and Innova Medical Group, Inc., a wholly owned subsidiary of Pasaca, to begin incorporating Quantum technology into Innova’s ecosystem of COVID-19 testing solutions.
As a result, Quantum secured substantial funding to move forward on major program initiatives. Pasaca also expedited introductions between Quantum and leaders in medical test and device manufacturing, healthcare, technology, media and telecom, transportation, banking sectors, and across the Asia-Pacific region.
Read More: https://investorshangout.com/post/view?id=606...z6nx4NwKor
$5++
PNJ1204 previously posted the case study but read it carefully!
Synergy, synergy, synergy.......... Rarely do we see two companies a Goliath and a David or little engine that could working in tandem!!!
From the Innova Medical Group Case Study on the Pasaca website...
“As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.”
So the anti-counterfeiting is ready for the Innova tests.
Read More: https://investorshangout.com/post/view?id=606...z6nx3NfyIu
Challenge
With pioneering technology and numerous potential applications, Quantum leadership made a strategic decision to list on NASDAQ , however early estimations were below value expectations. To better position itself for growth, Quantum needed capital support aligned with strategic partners for visibility and expansion into new markets, industries, and geographies.
Pasaca Impact
Pasaca Capital’s controlling investment in Quantum began with financing ongoing software/App development and sourcing leadership hires, such as the COO from their exclusive network. To secure sustainable revenue and profitability to fund growth, Pasaca facilitated a distribution agreement between Quantum and Innova Medical Group, Inc., a wholly owned subsidiary of Pasaca, to begin incorporating Quantum technology into Innova’s ecosystem of COVID-19 testing solutions.
As a result, Quantum secured substantial funding to move forward on major program initiatives. Pasaca also expedited introductions between Quantum and leaders in medical test and device manufacturing, healthcare, technology, media and telecom, transportation, banking sectors, and across the Asia-Pacific region.
Read More: https://investorshangout.com/post/view?id=606...z6nx4NwKor
$5++
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)